Zibo Tang

Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway

Yiyi Liu, Qingping Jiang, Xiong Liu et al. · EBioMedicine · 2019 · 104 citations · Full text

Medicine, Cancer Biology, Oncology +17

Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9

YongHao Li, Xiong Liu, Xian Lin et al. · Signal Transduction and Targeted Therapy · 2019 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer

Tongyuan Deng, Peng Shen, Aimin Li et al. · Theranostics · 2021 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17

miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway

Zibo Tang, WeiFeng Chen, Yan Xu et al. · Molecular Therapy — Nucleic Acids · 2020 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer

Yiyu Chen, Zhen Liu, Huijun Wang et al. · International Journal of Cancer · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17